Analytical method, adsorption inhibitor and analytical kit
By using oxalic acid or its salt as an adsorption inhibitor in liquid chromatography, the adsorption of compounds such as nucleotides and metals is prevented, and the detection sensitivity and accuracy problems are solved, and high-quality mass spectrometry analysis is achieved.
Patent Information
- Application Number
- CN201980072065.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2018-11-02
- Filing Date
- 2019-10-30
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2039-10-30
AI Technical Summary
In liquid chromatography, compounds with phosphoric acid groups such as nucleotides are prone to adsorption with metals, resulting in a decrease in detection sensitivity, deterioration of signal-to-noise ratio, and a decrease in accuracy.
Use a mobile phase containing oxalic acid or a salt thereof to prevent adsorption of compounds with phosphoric acid groups to metals, ionization is performed by electrospray in conjunction with mass spectrometry, and the addition of oxalic acid or a salt thereof to the mobile phase analyzed by liquid chromatography-mass spectrometry as adsorption inhibition agent.
It effectively inhibits metal adsorption of nucleotides and other compounds, improves detection sensitivity and accuracy, and ensures the quality of mass spectrometry analysis.
Smart Images

Figure CN112969915B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to an analytical method, an adsorption inhibitor and an analytical kit. Background Art
[0002] Compounds with phosphate groups play important roles in cells, etc. For example, nucleic acids formed by connecting nucleic acid bases via phosphodiester bonds of phosphate groups encode genetic information. Adenosine triphosphate (ATP) of nucleotides participates in various reactions using the energy accumulated in the bonds between phosphate groups.
[0003] Analysis of compounds having a phosphate group is important for analyzing the functions of living organisms, abnormalities that may be the cause of diseases, etc. For example, by quantifying cell metabolites, information on the production and decomposition of substances in cells can be obtained.
[0004] In the analysis of a sample containing multiple compounds such as the analysis of cell metabolites, the following operation is performed: a plurality of compounds are separated and analyzed by liquid chromatography-mass spectrometry (hereinafter referred to as LC / MS). However, a part of the compounds contained in the sample undergoes metal adsorption in the piping of the liquid chromatograph, etc., and therefore, there is a problem of reduced detection sensitivity. For example, the following is recorded in non-patent document 1: in order to prevent tetracycline antibiotics from causing tailing in liquid chromatography due to metal adsorption, oxalic acid is added to the mobile phase. In the method of non-patent document 1, oxalic acid is decomposed by atmospheric pressure chemical ionization to prevent contamination and clogging of the mass spectrometer.
[0005] Prior art literature
[0006] Non-patent literature
[0007] Non-patent document 1: Oka et al., "Food Analysis Based on LC / MS", HPC NEWS, Hayashi Pure Chemical Industries, January 13, 2002, Vol. 28, p. 1-11 Summary of the invention
[0008] Problem that the invention aims to solve
[0009] In liquid chromatography, in conventional mobile phases containing formic acid, compounds having phosphate groups such as nucleotides may be adsorbed by metals in pipes, etc. As a result, these compounds do not reach the analytical column, reducing sensitivity, or deteriorating the signal-to-noise ratio (S / N ratio) and reducing accuracy.
[0010] Solutions for solving problems
[0011] According to a first aspect of the present invention, an analysis method comprises the following steps: performing liquid chromatography using a mobile phase containing an adsorption inhibitor, wherein the adsorption inhibitor is used to prevent a sample containing a compound having a phosphate group from being adsorbed to a metal; and performing mass spectrometry analysis on an eluate of the liquid chromatography, wherein the adsorption inhibitor contains oxalic acid or a salt thereof.
[0012] According to a second aspect of the present invention, in the analysis method of the first aspect, the compound having a phosphate group is preferably at least one of a nucleic acid, a nucleotide, and a derivative thereof.
[0013] According to a third aspect of the present invention, in the analysis method of the first aspect or the second aspect, the sample preferably includes an extract derived from cells.
[0014] According to a fourth aspect of the present invention, in the analysis method of any one of the first to third aspects, the concentration of the oxalic acid or a salt thereof is preferably 0.1 mM or more and 50 mM or less.
[0015] According to a fifth aspect of the present invention, in the analysis method of any one of the first to fourth aspects, in the mass spectrometry, the sample is preferably ionized by an electrospray method.
[0016] According to a sixth aspect of the present invention, the adsorption inhibitor includes oxalic acid or a salt thereof, and the adsorption inhibitor is added to a mobile phase of liquid chromatography-mass spectrometry to prevent a sample including a compound having a phosphate group from being adsorbed to a metal.
[0017] According to a seventh aspect of the present invention, an analytical kit includes the adsorption inhibitor according to the sixth aspect.
[0018] Effects of the Invention
[0019] According to the present invention, compounds having a phosphate group such as nucleotides separated by liquid chromatography can be detected with high sensitivity or high accuracy in mass spectrometry. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 This is a conceptual diagram for explaining an analysis device according to one embodiment.
[0021] Figure 2 This is a conceptual diagram schematically showing an analysis kit according to one embodiment.
[0022] Figure 3 This is a flowchart showing the flow of an analysis method according to one embodiment.
[0023] Figure 4(A) is a mass spectrum obtained when a sample containing cytidine triphosphate (CTP) is subjected to liquid chromatography-tandem mass spectrometry (LC / MS / MS) using a mobile phase containing formic acid. Figure 4 (B) is a mass spectrum obtained when LC / MS / MS is performed on a sample containing CTP using a mobile phase containing oxalic acid.
[0024] Figure 5 This is a table showing the detection intensity of a sample containing cytidine diphosphate (CDP) and a sample containing guanosine diphosphate (GDP) when LC / MS / MS is performed using a mobile phase containing formic acid and a mobile phase containing oxalic acid. DETAILED DESCRIPTION
[0025] Hereinafter, this specific embodiment will be described with reference to the drawings.
[0026] -First Embodiment-
[0027] In the past, when a sample containing multiple compounds is subjected to LC / MS (hereinafter, "LC / MS" also includes the case of performing mass spectrometry analysis in two or more stages) in the analysis of intracellular metabolites, a mobile phase containing formic acid is used for the purpose of assisting ionization. However, in the conventional method using formic acid in the mobile phase, there is a problem of metal adsorption of compounds having phosphate groups such as nucleotides in piping, etc., as described above. In the analysis method of this embodiment, LC / MS is performed using a mobile phase containing oxalic acid, so that compounds having phosphate groups can be analyzed with good sensitivity.
[0028] (About the sample)
[0029] The sample is not particularly limited as long as it is a sample containing a compound having a phosphate group. The more phosphate groups the compound has, the higher the adsorption of metals, and therefore, the analysis method of the present embodiment can be suitably applied. From the perspective of importance as an analysis object, the compound having a phosphate group contained in the sample is preferably at least one of a nucleic acid, a nucleotide, and a derivative thereof. As long as the derivative has a phosphate group, the method of its derivatization is not particularly limited.
[0030] From the viewpoint of containing various substances and effectively applying separation analysis based on LC / MS, the sample is preferably collected from an organism. However, it can also be a substance that is not from an organism, such as an artificially synthesized nucleic acid, nucleotide or their derivatives. When the sample is an extract from a cell, it is more preferred because LC / MS can be used to effectively separate and analyze the components contained in the cell. When the sample contains cell metabolites, it is further preferred because compounds with phosphate groups related to metabolic reactions can be suitably analyzed.
[0031] (About pre-processing)
[0032] There is no particular limitation on the method for pre-treatment of the sample as long as the sample for analysis is prepared in a manner including the components to be analyzed and LC / MS is performed with the desired accuracy. In the pre-treatment, extraction, concentration and other purification are appropriately performed from the collected sample in a manner including the components to be analyzed. When the sample is a cell or tissue from an organism and metabolites are analyzed, for example, after separating the cytoplasmic components by crushing, hydrophilic metabolites are extracted by methanol-chloroform extraction, etc., and the extracted hydrophilic metabolites are concentrated. The resulting solution is appropriately diluted and introduced into a liquid chromatograph.
[0033] (About the analysis device)
[0034] The liquid chromatography and mass spectrometry in the analysis method of the present embodiment are preferably performed using a liquid chromatograph-mass spectrometer as an analysis apparatus, but analysis can also be performed using a liquid chromatograph and a mass spectrometer that are controlled separately.
[0035] Figure 1 1 is a conceptual diagram showing the configuration of an analysis device for the analysis method of the present embodiment. The analysis device 1 includes a measurement unit 100 and an information processing unit 40. The measurement unit 100 includes a liquid chromatograph 10 and a mass spectrometer 20.
[0036] The liquid chromatograph 10 includes mobile phase containers 11a and 11b, liquid delivery pumps 12a and 12b, a sample introduction unit 13, and an analytical column 14. The mass spectrometer 20 includes an ionization chamber 21 including an ionization unit 211, a first vacuum chamber 22a including an ion lens 221, a tube 212 for introducing ions from the ionization chamber 21 to the first vacuum chamber 22a, a second vacuum chamber 22b including an ion guide 222, and a third vacuum chamber 22c. The third vacuum chamber 22c includes a first mass separation unit 23, a collision cell 24, a second mass separation unit 25, and a detection unit 30. The collision cell 24 includes an ion guide 240 and a CID gas introduction port 241.
[0037] The information processing unit 40 includes an input unit 41, a communication unit 42, a storage unit 43, an output unit 44, and a control unit 50. The control unit 50 includes a device control unit 51, an analysis unit 52, and an output control unit 53.
[0038] The liquid chromatograph 10 separates the introduced sample S by liquid chromatography. The type of the liquid chromatograph 10 is not particularly limited as long as it can separate the sample with desired accuracy. As the liquid chromatograph 10, nano LC, microflow LC, high performance liquid chromatograph (HPLC), ultra high performance liquid chromatograph (UHPLC), etc. can be used.
[0039] The mobile phase containers 11a and 11b are containers such as vials and bottles that can hold liquids and contain mobile phases having different compositions. The mobile phases contained in the mobile phase containers 11a and 11b are referred to as mobile phase A and mobile phase B, respectively.
[0040] At least one of the mobile phase A and the mobile phase B contains oxalic acid. The concentration of oxalic acid contained in the mobile phase A or the mobile phase B is preferably 0.1 mM or more, more preferably 0.5 mM or more. The higher the concentration of oxalic acid, the more it can significantly suppress the metal adsorption of the compound having a phosphate group. In other words, oxalic acid functions as an adsorption inhibitor for preventing the sample containing the compound having a phosphate group from being adsorbed to the metal. If the concentration of oxalic acid is too high, the sensitivity in mass spectrometry analysis is reduced, and therefore, the concentration of oxalic acid contained in the mobile phase A or the mobile phase B is preferably 50 mM or less, more preferably 10 mM or less. The oxalic acid concentrations of the mobile phase A and the mobile phase B are preferably substantially the same.
[0041] It should be noted that the mobile phase may contain a salt of oxalic acid.
[0042] The types of solvents of mobile phase A and mobile phase B are not particularly limited, and the composition of the mobile phase is determined so that the ratio of the aqueous solvent to the organic solvent in mobile phase A and mobile phase B is different. For example, the solvent of mobile phase A can be water, and the solvent of mobile phase B can be acetonitrile.
[0043] The liquid delivery pumps 12a and 12b deliver liquids so that the mobile phase A and the mobile phase B reach a predetermined flow rate. The mobile phase A and the mobile phase B respectively delivered from the liquid delivery pumps 12a and 12b are mixed in the middle of the flow path and introduced into the sample introduction part 13. The liquid delivery pumps 12a and 12b change the flow rates of the mobile phase A and the mobile phase B respectively, thereby changing the composition of the mobile phase introduced into the analytical column 14 over time.
[0044] The information indicating the composition of the mobile phase at each time from the time corresponding to the start of analysis such as the introduction of the sample S is called a gradient program. The liquid delivery pumps 12a and 12b are controlled based on the gradient program, and the mobile phase of the set composition is introduced into the analytical column 14. The data corresponding to the gradient program is stored in the storage unit 43, and the device control unit 51 controls the liquid delivery pumps 12a and 12b with reference to the data.
[0045] The sample introduction unit 13 includes a sample introduction device such as an autosampler, and introduces the analytical sample S prepared by pretreatment into the mobile phase (arrow A1). The sample S introduced through the sample introduction unit 13 passes through a guard column (not shown) as appropriate and is introduced into the analytical column 14.
[0046] The analytical column 14 is provided with a stationary phase, and each component contained in the introduced sample S is eluted at different retention times by utilizing the difference in affinity of the component for the mobile phase and the stationary phase. The type of the analytical column 14 is not particularly limited as long as it can separate the components of the sample S with the desired accuracy. From the viewpoint of suitably separating alkali, nitrogen or amine, a PFPP (pentafluorophenylpopyl) column is preferably used. The PFPP column is a column containing pentafluorophenylpropyl in the stationary phase. When a metal is contained in the filler of the analytical column 14, metal adsorption of the sample is likely to occur, and the analytical method of the present embodiment can be suitably applied, so it is preferred.
[0047] The eluate eluted from the analytical column 14 is introduced into the ionization unit 211 of the mass spectrometer 20. The eluate from the analytical column 14 is preferably input into the mass spectrometer 20 by online control without requiring the user of the analysis apparatus 1 (hereinafter referred to as "user") to perform operations such as dispensing.
[0048] The mass spectrometer 20 performs tandem mass spectrometry on the eluted sample introduced from the analytical column 14, and detects ions corresponding to the components of the sample, especially the compounds having a phosphate group, as the analysis object. The dotted arrow A2 schematically shows the path of the sample ions Si obtained by ionization of the eluted sample. Here, the sample ions Si also include ions generated by the dissociation of the sample ions Si.
[0049] It should be noted that the configuration of each component of the mass spectrometer 20 is not particularly limited as long as the sample ions Si can be detected with desired accuracy.
[0050] The ionization section 211 of the mass spectrometer 20 ionizes the introduced eluted sample. The ionization method is not particularly limited as long as the eluted sample is ionized to a degree that the component to be analyzed can be detected with the desired accuracy. When LC / MS / MS is performed as in the present embodiment, the electrospray method (ESI) is preferably used. In the following embodiments, it is also described as a method of performing ESI. The sample ions Si generated by emitting from the ionization section 211 move due to the pressure difference between the ionization chamber 21 and the first vacuum chamber 22a, and are incident into the first vacuum chamber 22a through the tube 212.
[0051] The first vacuum chamber 22a, the second vacuum chamber 22b, and the third vacuum chamber 22c are evacuated by vacuum pumps (not shown) respectively, and the vacuum degree is successively increased. In the third vacuum chamber 22c, the vacuum is evacuated to, for example, 10 -2Pa or less. The ions incident into the first vacuum chamber 22a are introduced into the second vacuum chamber 22b through the ion lens 221. The ions incident into the second vacuum chamber 22b pass through the ion guide 222 and are introduced into the third vacuum chamber 22c. The ions introduced into the third vacuum chamber 22c are ejected toward the first mass separation unit 23. During the period until the ions are incident into the first mass separation unit 23, the ion lens 221, the ion guide 222, etc. collect the passing ions by electromagnetic action.
[0052] The first mass separation unit 23 includes a quadrupole mass filter, and through the electromagnetic effect of the voltage applied to the quadrupole mass filter, ions having a set m / z (excluding a difference of a certain coefficient, corresponding to the mass-to-charge ratio) are selectively passed as precursor ions and ejected toward the collision cell 24. The first mass separation unit 23 selectively allows the sample ions Si to be analyzed to pass as precursor ions.
[0053] The collision cell 24 controls the movement of ions through the ion guide 240, and dissociates the sample ions Si of the analysis object through collision induced dissociation (CID) to generate fragment ions. During CID, a gas containing argon, nitrogen, etc. (hereinafter referred to as CID gas) is introduced from the CID gas inlet 241 in such a way that a predetermined pressure is reached in the collision cell (arrow A3). The sample ions Si containing the generated fragment ions are ejected toward the second mass separation unit 25.
[0054] The second mass separation unit 25 includes a quadrupole mass filter, and selectively allows fragment ions having a set m / z to pass therethrough by an electromagnetic action based on a voltage applied to the quadrupole mass filter, and emits the fragment ions toward the detection unit 30 .
[0055] The detection unit 30 is equipped with a secondary electron multiplier tube, a photoelectron multiplier tube plasma detector, and detects the incident fragment ions. The detection mode can be any one of a positive ion mode for detecting positive ions and a negative ion mode for detecting negative ions. The detection signal obtained by detecting the fragment ions is A / D converted by an A / D converter (not shown) to form a digital signal, and is input into the control unit 50 of the information processing unit 40 in the form of measurement data (arrow A4).
[0056] The information processing unit 40 includes an information processing device such as a computer, and appropriately serves as an interface with the user, and performs communication, storage, calculation, etc. on various data. The information processing unit 40 is an information processing device that performs control, analysis, and display processing of the measurement unit 100.
[0057] It should be noted that the information processing unit 40 can be configured as a device that is integrated with the liquid chromatograph 10 and the mass spectrometer 20. In addition, part of the data used in the analysis method of this embodiment can be stored in a remote server, etc., and part of the calculation processing performed using the analysis method can also be performed using a remote server, etc. The operation control of each part of the measurement unit 100 can be performed by the information processing unit 40, or by the devices constituting each part.
[0058] The input unit 41 of the information processing unit 40 includes input devices such as a mouse, a keyboard, various keys, and / or a touch panel. The input unit 41 receives information necessary for processing by the control unit 50, such as the m / z value of an ion to be detected, from a user.
[0059] The communication unit 42 of the information processing unit 40 is composed of a communication device that can communicate by wireless or wired connection via a network such as the Internet. The communication unit 42 receives data necessary for the measurement of the measurement unit 100, or outputs data processed by the control unit 50 such as the analysis result of the analysis unit 52, or receives and outputs appropriate necessary data.
[0060] The storage unit 43 of the information processing unit 40 includes a nonvolatile storage medium and stores measurement data output from the measurement unit 100 and a program for causing the control unit 50 to execute processing.
[0061] The output unit 44 of the information processing unit 40 is controlled by the output control unit 53, and is composed of at least one of a display device such as a liquid crystal monitor and a printer. It displays information related to the measurement of the measuring unit 100, information corresponding to the analysis results of the analysis unit 52, etc. on the display device or prints it on a printed medium for output.
[0062] The control unit 50 of the information processing unit 40 includes a processor such as a CPU. The control unit 50 performs various processes by executing a program stored in the storage unit 43 or the like, such as controlling the measurement unit 100 and analyzing measurement data output from the measurement unit 100 .
[0063] The device control unit 51 of the processing unit 50 controls the measurement operation of the measurement unit 100 based on the analysis conditions set by the input via the input unit 41. The device control unit 51 controls the flow rate of the liquid delivery pumps 12a and 12b, controls the dissociation in the collision cell 24, controls the m / z value of the ions selectively passed in the first mass separation unit 23 and the second mass separation unit 25, and the like.
[0064] The analyzing unit 52 performs analysis such as quantification of the target component in the sample based on the measurement data output from the measuring unit 100. The analyzing unit 52 acquires the detection intensity corresponding to the target component from the measurement data output from the detecting unit 30 and stores it in the storing unit 43 or the like.
[0065] When the analysis unit 52 measures the internal standard, it calculates the value obtained by dividing the detection intensity corresponding to the component to be analyzed by the detection intensity corresponding to the internal standard and multiplying it by the concentration of the internal standard introduced as the amount of each component. When the internal standard is not used, the standardized intensity obtained by standardizing the detection intensity of the substance or substance group serving as the reference may also be calculated. In addition, the analysis unit 52 creates data corresponding to the chromatogram, which corresponds the retention time to the detection intensity.
[0066] It should be noted that the analysis method by the analysis unit 52 is not particularly limited.
[0067] The output control unit 53 creates an output image including information on analysis conditions, information obtained by analysis by the analysis unit 52 , and the like, and outputs the image to the output unit 44 .
[0068] (Analysis kit)
[0069] Figure 2 Schematically shows an analysis kit used in the analysis method of the present embodiment. The analysis kit 9 includes an adsorption inhibitor 90 for preventing a sample S containing a compound having a phosphate group from being adsorbed to a metal, and the adsorption inhibitor 90 contains oxalic acid or a salt thereof. The adsorption inhibitor 90 is stored in a vial 91, and the type, size, and shape of the container storing the adsorption inhibitor 90 are not particularly limited.
[0070] It should be noted that the analysis kit 9 may include, in addition to the adsorption inhibitor 90 , any consumables used in liquid chromatography or mass spectrometry.
[0071] Figure 3 1 is a flowchart showing the flow of the analysis method of this embodiment. In step S1001, the analyst, user, etc. prepares the sample S. After step S1001 is completed, step S1003 is started. In step S1003, the analyst, user, etc. pre-processes the sample. After step S1003 is completed, step S1005 is started.
[0072] In step S1005, the liquid chromatograph 10 uses a mobile phase containing oxalic acid or a salt thereof to separate the sample S by liquid chromatography. After step S1005, step S1007 starts. In step S1007, the mass spectrometer 20 performs mass spectrometry on the sample S provided for liquid chromatography. After step S1007, step S1009 starts.
[0073] In step S1009, the analysis unit 52 analyzes the measurement data obtained by mass spectrometry. After step S1009 is completed, step S1011 is started. In step S1011, the output unit 44 outputs the information obtained by the analysis. After step S1011 is completed, the processing ends.
[0074] According to the above-described embodiment, the following effects can be obtained.
[0075] (1) The analysis method of this embodiment includes: performing liquid chromatography using a mobile phase containing an adsorption inhibitor for preventing a sample S containing a compound having a phosphate group from being adsorbed to a metal; and performing mass spectrometry on an eluate of the liquid chromatography, wherein the adsorption inhibitor contains oxalic acid or a salt thereof. Thus, metal adsorption of compounds having a phosphate group such as nucleotides can be suppressed in liquid chromatography, and these compounds can be detected with good sensitivity or good accuracy in mass spectrometry.
[0076] (2) In the analysis method of the present embodiment, in mass spectrometry, the sample S is ionized by the electrospray method. This allows molecules of various molecular weights contained in a living body or the like to be appropriately ionized without being destroyed.
[0077] (3) The adsorption inhibitor of this embodiment includes oxalic acid or a salt thereof, which is added to the mobile phase of liquid chromatography-mass spectrometry to prevent the sample containing a compound having a phosphate group from being adsorbed to a metal. Thus, the metal adsorption of compounds having a phosphate group such as nucleotides can be suppressed in liquid chromatography, and these compounds can be detected with good sensitivity or good accuracy in mass spectrometry.
[0078] (4) The analysis kit of the present embodiment includes the adsorption inhibitor 90. This allows the above-mentioned analysis to be performed rapidly.
[0079] The following modifications are also within the scope of the present invention and can be combined with the above-described embodiment. In the following modifications, the same reference numerals are used for the same components and display functions as those in the above-described embodiment, and the description thereof is omitted as appropriate.
[0080] (Variant 1)
[0081] The analysis device 1 of the above embodiment is a triple quadrupole mass spectrometer, but the configuration of the mass spectrometer 20 is not particularly limited. The mass spectrometer 20 may include a mass separation unit consisting of one mass spectrometer, or may include a mass separation unit consisting of two or more mass spectrometers in a different combination from the above embodiment. For example, the analysis device 1 may include an ion trap or a time-of-flight mass separation unit.
[0082] The dissociation method is not limited to the above-mentioned CID, and can be appropriately selected according to the type of the analysis device 1 and the characteristics of the molecule to be analyzed, such as photoinduced dissociation, electron capture dissociation, or electron transfer dissociation.
[0083] The present invention is not limited to the contents of the above-mentioned embodiment, and other embodiments that can be conceived within the technical concept of the present invention are also included in the scope of the present invention.
[0084] Example
[0085] In the following examples, the results obtained by performing LC / MS / MS on a sample containing nucleotides of known concentration using a mobile phase containing formic acid and a mobile phase containing oxalic acid are described.
[0086] It should be noted that the present invention is not limited to the numerical values and conditions shown in the following examples.
[0087] (Comparative Example 1)
[0088] In Comparative Example 1, a 0.1 μM CTP solution was analyzed using a mobile phase to which 0.1 vol % formic acid was added.
[0089] Liquid chromatography conditions
[0090] The analytical sample was separated by liquid chromatography under the following conditions.
[0091] System: NexeraX2 (Shimadzu)
[0092] Analytical column: Discovery HS F5-3 (Sigma-Aldrich) (inner diameter 2.1 mm, length 150 mm, particle size 3 μm)
[0093] Injection volume: 3μL
[0094] Column temperature: 40°C
[0095] Mobile Phase:
[0096] (A) 0.1% formic acid (dissolved in water)
[0097] (B) 0.1% formic acid (dissolved in acetonitrile)
[0098] Flow rate: 0.25mL / min
[0099] Gradient Program:
[0100]
[0101] Conditions for mass spectrometry analysis
[0102] The eluted sample eluted in the above-mentioned liquid chromatography was detected by tandem mass spectrometry directly connected to the elution port.
[0103] System: LCMS-8050 (Shimadzu)
[0104] Ionization method: electrospray, positive ion mode
[0105] Measurement mode: Multiple reaction monitoring (MRM)
[0106] temperature:
[0107] Desolvation Line (DL) temperature: 250°C
[0108] Heating block temperature: 400°C
[0109] Interface temperature: 300℃
[0110] Gas flow:
[0111] Nebulizer gas flow rate: 3.0L / min
[0112] Drying gas flow rate: 10.0L / min
[0113] Heating gas flow rate: 10.0L / min
[0114] As an ion corresponding to CTP, a precursor ion of m / z 483.90 was separated and subjected to CID, and then a product ion of m / z 112.20 was separated and detected.
[0115] Figure 4 (A) is a mass spectrum obtained by mass spectrometry analysis of Comparative Example 1. The intensity of each peak is very small, and CTP cannot be substantially detected.
[0116] (Example 1)
[0117] In Example 1, a 0.1 μM CTP solution was analyzed using a mobile phase supplemented with 10 mM oxalic acid.
[0118] Liquid chromatography conditions
[0119] The analytical sample was separated by liquid chromatography under the following conditions.
[0120] System: NexeraX2 (Shimadzu)
[0121] Analytical column: Discovery HS F5-3 (Sigma-Aldrich) (inner diameter 2.1 mm, length 150 mm, particle size 3 μm)
[0122] Injection volume: 3μL
[0123] Column temperature: 40°C
[0124] Mobile Phase:
[0125] (A) 10 mM oxalic acid (dissolved in water)
[0126] (B) 10 mM oxalic acid (dissolved in acetonitrile)
[0127] Flow rate: 0.3mL / min
[0128] Gradient Program:
[0129]
[0130] Conditions for mass spectrometry analysis
[0131] The eluted sample eluted in the above-mentioned liquid chromatography was detected by tandem mass spectrometry directly connected to the elution port.
[0132] System: LCMS-8050 (Shimadzu)
[0133] Ionization method: electrospray, positive ion mode
[0134] Measurement mode: MRM
[0135] temperature:
[0136] Desolventizing tube (DL) temperature: 250℃
[0137] Heating block temperature: 400°C
[0138] Interface temperature: 300℃
[0139] Gas flow:
[0140] Nebulizer gas flow rate: 3.0L / min
[0141] Drying gas flow rate: 10.0L / min
[0142] Heating gas flow rate: 10.0L / min
[0143] As an ion corresponding to CTP, a precursor ion of m / z 483.90 was separated and subjected to CID, and then a product ion of m / z 112.20 was separated and detected.
[0144] Figure 4 (B) is a mass spectrum obtained by mass spectrometry analysis of Example 1. In Example 1, a peak corresponding to CTP was detected which was much larger than the peaks of Comparative Example 1. In Example 1, no significant increase in noise was observed, and the S / N ratio was also increased.
[0145] (Comparative Example 2)
[0146] In Comparative Example 2, a 0.1 μM cytidine diphosphate (CDP) solution and a 0.1 μM guanosine diphosphate (GDP) solution were analyzed using a mobile phase supplemented with 0.1 vol% formic acid under substantially the same conditions as in Comparative Example 1. In mass spectrometry, transitions were set to detect CDP and GDP, respectively.
[0147] (Example 2)
[0148] In Example 2, a 0.1 μM CDP solution and a 0.1 μM GDP solution were analyzed using a mobile phase supplemented with 10 mM oxalic acid under substantially the same conditions as in Example 1. In mass spectrometry, transitions were set so that CDP and GDP were detected separately.
[0149] Figure 5 : is a table showing the results of Comparative Example 2 and Example 2. As the detection intensity of the sample, the area of the peak corresponding to the sample after background removal is shown. The number of phosphate groups in CDP and GDP is less than that of ATP, and it is believed that the adverse effects caused by metal adsorption are also less, but even when these molecules are used as samples, the sensitivity can be improved by using an oxalic acid-based mobile phase compared to the case of using a formic acid-based mobile phase.
[0150] The disclosures of the following priority basic applications are incorporated herein as references.
[0151] Japanese Patent Application No. 2018-207620 (filed on November 2, 2018)
[0152] Description of Reference Numerals
[0153] 1 ...analyzing device, 9 ...analytical reagent kit, 10 ...liquid chromatograph, 11a, 11b ...mobile phase container, 14 ...analytical column, 20 ...mass spectrometer, 21 ...ionization chamber, 23 ...first mass separation unit, 24 ...collision cell, 25 ...second mass separation unit, 30 ...detection unit, 40 ...information processing unit, 50 ...control unit, 51 ...device control unit, 52 ...analyzing unit, 53 ...output control unit, 90 ...adsorption inhibitor, 100 ...measuring unit, 211 ...ionization unit, S ...sample, Si ...sample ion.
Claims
1. An analysis method comprising the following steps: performing liquid chromatography using a mobile phase containing an adsorption inhibitor for preventing a sample containing a compound having a phosphate group from being adsorbed to a metal in a stationary phase; and The eluate from the liquid chromatography is subjected to mass spectrometry analysis, The adsorption inhibitor comprises oxalate.
2. The analysis method according to claim 1, wherein The compound having a phosphate group is at least one of a nucleic acid, a nucleotide, and a derivative thereof.
3. The analysis method according to claim 1 or 2, wherein: The sample comprises an extract from cells.
4. The analysis method according to claim 1 or 2, wherein: The concentration of the oxalate is 0.1 mM or more and 50 mM or less.
5. The analysis method according to claim 1 or 2, wherein: In the mass spectrometry analysis, the sample is ionized by electrospray ionization.
6. Use of an adsorption inhibitor for preventing a sample containing a compound having a phosphate group from being adsorbed onto a metal in a stationary phase, The adsorption inhibitor comprises oxalate, The adsorption inhibitor is added to the mobile phase of liquid chromatography-mass spectrometry analysis.
7. The use according to claim 6, wherein The adsorption inhibitor is contained in an analytical kit.
